BIOGEN INC. — Director's Dealing 2016

Jun 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2016-05-31

Reporting Person: SCANGOS GEORGE A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-31	Common Stock	S	3368	$290.00	Disposed	56265	Direct
2016-06-01	Common Stock	S	487	$287.97	Disposed	55778	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5378	Indirect
Common Stock	5378	Indirect

Footnotes

F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.